TNF-α induces matrix metalloproteinase-9-dependent soluble intercellular adhesion molecule-1 release via TRAF2-mediated MAPKs and NF-κB activation in osteoblast-like MC3T3-E1 cells

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Tsai, Chia Lan ^a   Chen, Wei Chung ^a   Hsieh, Hsi Lung ^b   Chi, Pei Ling ^a   Hsiao, Li Der ^a   Yang, Chuen Mao ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

MAPKs; MMP 9; Osteoblast like MC3T3 E1 cells; Soluble ICAM 1; TNF

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ANIMAL; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; OSTEITIS; OSTEOBLAST; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; NF-KAPPA B; OSTEITIS; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893179684     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-21-12     Document Type: Article

References (50)

1. Matrix metalloproteinases: effectors of development and normal physiology. Vu TH, Werb Z, Genes Dev 2000 14 2123 2133
2. Extracellular matrix remodelling: the role of matrix metalloproteinases. Stamenkovic I, J Pathol 2003 200 448 464 (Pubitemid 36818245)
3. The cell surface: the stage for matrix metalloproteinase regulation of migration. Seiki M, Curr Opin Cell Biol 2002 14 624 632 (Pubitemid 35247747)
4. Matrix metalloproteinases and bone. Krane SM, Inada M, Bone 2008 43 7 18
5. Matrix metalloproteinases and the regulation of tissue remodelling. Page-McCaw A, Ewald AJ, Werb Z, Nat Rev Mol Cell Biol 2007 8 221 233
6. Proteinases in the joint: clinical relevance of proteinases in joint destruction. Rengel Y, Ospelt C, Gay S, Arthritis Res Ther 2007 9 221
7. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ, Arthritis Rheum 1996 39 1576 1587 (Pubitemid 26314993)
8. ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. Prasadam I, van Gennip S, Friis T, Shi W, Crawford R, Xiao Y, Arthritis Rheum 2010 62 1349 1360
9. Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide- stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Lee WJ, Shin CY, Yoo BK, Ryu JR, Choi EY, Cheong JH, Ryu JH, Ko KH, Glia 2003 41 15 24 (Pubitemid 36164281)
10. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Yokoo T, Kitamura M, Am J Physiol 1996 270 123 F130
11. Osteoclasts are essential for TNF-alpha-mediated joint destruction. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G, J Clin Invest 2002 110 1419 1427 (Pubitemid 35396913)
12. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Sundaram K, Nishimura R, Senn J, Youssef RF, London SD, Reddy SV, Exp Cell Res 2007 313 168 178 (Pubitemid 44958461)
13. Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors. Ben DD, Reznick AZ, Srouji S, Livne E, Histochem Cell Biol 2008 129 589 597
14. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Kaneko M, Tomita T, Nakase T, Ohsawa Y, Seki H, Takeuchi E, Takano H, Shi K, Takahi K, Kominami E, et al. Rheumatology (Oxford) 2001 40 247 255
15. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Romas E, Gillespie MT, Martin TJ, Bone 2002 30 340 346 (Pubitemid 34154863)
16. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis. Catrina AI, af Klint E, Ernestam S, Catrina SB, Makrygiannakis D, Botusan IR, Klareskog L, Ulfgren AK, Arthritis Rheum 2006 54 76 81 (Pubitemid 43122189)
17. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. Eberhardt W, Huwiler A, Beck KF, Walpen S, Pfeilschifter J, J Immunol 2000 165 5788 5797
18. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Han J, Lee JD, Bibbs L, Ulevitch RJ, Science 1994 265 808 811 (Pubitemid 24266145)
19. The stress-activated protein kinase subfamily of c-Jun kinases. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR, Nature 1994 369 156 160 (Pubitemid 24153440)
20. Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway. Li W, Li H, Bocking AD, Challis JR, Biol Reprod 2010 83 481 487
21. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. Barnes PJ, Karin M, N Engl J Med 1997 336 1066 1071 (Pubitemid 27163860)
22. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: involvement of the ras dependent pathway. Moon SK, Cha BY, Kim CH, J Cell Physiol 2004 198 417 427
23. Involvement of ICAM-1 in bone metabolism: a potential target in the treatment of bone diseases? Lavigne P, Benderdour M, Shi Q, Lajeunesse D, Fernandes JC, Expert Opin Biol Ther 2005 5 313 320 (Pubitemid 40516742)
24. An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro. Fernandes JC, Shi Q, Benderdour M, Lajeunesse D, Lavigne P, J Bone Miner Metab 2008 26 543 550
25. Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast development. Kurachi T, Morita I, Murota S, Biochim Biophys Acta 1993 1178 259 266 (Pubitemid 23276218)
26. Involvement of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in osteoclastogenesis: a possible role in direct interaction between osteoclast precursors. Harada H, Kukita T, Kukita A, Iwamoto Y, Iijima T, Endocrinology 1998 139 3967 3975 (Pubitemid 28512280)
27. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Witkowska AM, Borawska MH, Eur Cytokine Netw 2004 15 91 98 (Pubitemid 38980081)
28. Soluble selectins and ICAM-1 modulate neutrophil-endothelial adhesion and diapedesis in vitro. Ohno N, Ichikawa H, Coe L, Kvietys PR, Granger DN, Alexander JS, Inflammation 1997 21 313 324 (Pubitemid 27367832)
29. Evidence for two distinct pathways in TNFalpha-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients. Shi Q, Benderdour M, Lavigne P, Ranger P, Fernandes JC, Osteoarthr Cartilage 2007 15 300 308 (Pubitemid 46238245)
30. Osteoporosis and inflammation. Lacativa PG, Farias ML, Arq Bras Endocrinol Metabol 2010 54 123 132
31. Cell adhesion molecules: potential therapeutic & diagnostic implications. Mousa SA, Mol Biotechnol 2008 38 33 40 (Pubitemid 351378095)
32. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, Sung JH, Wozney JM, Kim HJ, Ryoo HM, J Biol Chem 2003 278 34387 34394 (Pubitemid 37553284)
33. Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-delta-dependent ERK/Elk-1 pathway in astrocytes. Hsieh HL, Wu CY, Yang CM, Glia 2008 56 619 632
34. Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1. Hsieh HL, Yen MH, Jou MJ, Yang CM, Cell Signal 2004 16 1163 1176
35. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, Imam SZ, Greene WC, Valente AJ, J Biol Chem 2006 281 15099 15109 (Pubitemid 43855099)
36. Granulocyte-macrophage colony-stimulating factor- and tumor necrosis factor alpha-mediated matrix metalloproteinase production by human osteoblasts and monocytes after infection with Brucella abortus. Scian R, Barrionuevo P, Giambartolomei GH, Fossati CA, Baldi PC, Delpino MV, Infect Immun 2011 79 192 202
37. TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion. Hisanaga T, Terai S, Iwamoto T, Takami T, Yamamoto N, Murata T, Matsuyama T, Nishina H, Sakaida I, Cell Tissue Res 2011 346 79 88
38. TNF-alpha induces matrix metalloproteinase-9 expression in A549 cells: role of TNFR1/TRAF2/PKCalpha-dependent signaling pathways. Lee IT, Lin CC, Wu YC, Yang CM, J Cell Physiol 2010 224 454 464
39. Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. Pincheira R, Castro AF, Ozes ON, Idumalla PS, Donner DB, J Immunol 2008 181 1288 1298
40. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells. Lin CC, Tseng HW, Hsieh HL, Lee CW, Wu CY, Cheng CY, Yang CM, Toxicol Appl Pharmacol 2008 229 386 398
41. Matrix metalloproteinases in neuroinflammation. Rosenberg GA, Glia 2002 39 279 291
42. Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis. Lynch CC, Bone 2011 48 44 53
43. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Nanes MS, Gene 2003 321 1 15 (Pubitemid 37421390)
44. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Abbas S, Zhang YH, Clohisy JC, bu-Amer Y, Cytokine 2003 22 33 41 (Pubitemid 37222300)
45. TNF receptor-1 (TNF-R1) ubiquitous scaffolding and signaling protein interacts with TNF-R1 and TRAF2 via an N-terminal docking interface. Terry Powers JL, Mace KE, Parfrey H, Lee SJ, Zhang G, Riches DW, Biochemistry 2010 49 7821 7829
46. Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. van Vliet C, Bukczynska PE, Puryer MA, Sadek CM, Shields BJ, Tremblay ML, Tiganis T, Nat Immunol 2005 6 253 260 (Pubitemid 41724762)
47. Proinflammatory cytokines, IL-1beta and TNF-alpha, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-kappaB pathway but not p38 pathway in osteoblasts. Eda H, Shimada H, Beidler DR, Monahan JB, Rheumatol Int 2011 31 1525 1530
48. Role of NF-kappaB in the skeleton. Novack DV, Cell Res 2011 21 169 182
49. c-Src-dependent MAPKs/AP-1 activation is involved in TNF-α-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells. Yang CM, Lee IT, Lin CC, Wang CH, Cherng WJ, Hsiao LD, Biochem Pharmacol 2013 85 1115 1123
50. Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption. Okada Y, Morimoto I, Ura K, Watanabe K, Eto S, Kumegawa M, Raisz L, Pilbeam C, Tanaka Y, Endocr J 2002 49 483 495 (Pubitemid 34988240)